97 related articles for article (PubMed ID: 11503055)
21. Personalized therapy in chronic viral hepatitis.
Brunetto MR; Colombatto P; Bonino F
Mol Aspects Med; 2008; 29(1-2):103-11. PubMed ID: 18068759
[TBL] [Abstract][Full Text] [Related]
22. [The clinical study on chronic hepatitis B treated by the four-step therapeutics of Traditional Chinese Medicine].
Yang HZ; Wang FL; Wang YZ; Shen WS; Xu GL; Yang YW; Huang XL
Zhong Yao Cai; 2006 Jul; 29(7):748-52. PubMed ID: 17059015
[TBL] [Abstract][Full Text] [Related]
23. The use of tissue polypeptide specific antigen as a marker in liver diseases.
Cetin T; Oğuz A; Algan P; Yildirim IS
Turk J Gastroenterol; 2003 Sep; 14(3):177-80. PubMed ID: 14655061
[TBL] [Abstract][Full Text] [Related]
24. [Effect of artificial liver support system on the patients with severe hepatitis].
Li CZ; Tan DM; Liu SH
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):377-8. PubMed ID: 12536744
[TBL] [Abstract][Full Text] [Related]
25. [Single factor study of prognosis from 520 cases with chronic severe hepatitis].
Zou Z; Chen J; Xin S; Xing H; Li B; Li J; Shen H; Liu Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):246-8. PubMed ID: 12665931
[TBL] [Abstract][Full Text] [Related]
26. [Detection of serum free insulin-like growth factor 1 in patients with chronic viral hepatitis].
Lou M; Song N; Jin X; Luo SQ; Wang JJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):291-2. PubMed ID: 11986710
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy of Lugua polypeptide injection on active rheumatoid arthritis].
Guo SY; Lin LJ; Chu H; Yang C; Gong DD; Tian J; Fu HX
Zhongguo Gu Shang; 2008 Aug; 21(8):610-2. PubMed ID: 19108379
[TBL] [Abstract][Full Text] [Related]
28. Changes in intestinal microflora in patients with chronic severe hepatitis.
Li L; Wu Z; Ma W; Yu Y; Chen Y
Chin Med J (Engl); 2001 Aug; 114(8):869-72. PubMed ID: 11780370
[TBL] [Abstract][Full Text] [Related]
29. [Clinical evaluation of therapeutic effects of "Cooling the blood and invigorating blood circulation" method on hepatitis hyperbilirubinemia].
Li YZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):73-4. PubMed ID: 16642224
[TBL] [Abstract][Full Text] [Related]
30. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of prognostic factors of and to establish a predictive model for patients with chronic severe hepatitis].
Zhang N; Wang YM; Deng GH; Yi D
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):730-3. PubMed ID: 16248942
[TBL] [Abstract][Full Text] [Related]
32. Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study.
Huber R; Lüdtke R; Klassen M; Müller-Buscher G; Wolff-Vorbeck G; Scheer R
Eur J Med Res; 2001 Sep; 6(9):399-405. PubMed ID: 11669085
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic vaccination in the immunotolerant phase of children with chronic hepatitis B infection.
Dikici B; Kalayci AG; Ozgenc F; Bosnak M; Davutoglu M; Ece A; Ozkan T; Ozeke T; Yagci RV; Haspolat K
Pediatr Infect Dis J; 2003 Apr; 22(4):345-9. PubMed ID: 12690275
[TBL] [Abstract][Full Text] [Related]
34. A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection.
Yao G; Wang B; Cui Z; Yao J; Zeng M
Chin Med J (Engl); 1999 May; 112(5):387-91. PubMed ID: 11593504
[TBL] [Abstract][Full Text] [Related]
35. Clinical-epidemiological features, diagnostics, treatment of chronic viral hepatitises, combined with opisthorchosis in inhabitants of Siberia and the Northern regions of Russia.
Paltsev AI
Alaska Med; 2007; 49(2 Suppl):153-60. PubMed ID: 17929626
[TBL] [Abstract][Full Text] [Related]
36. [Anti-HBV efficacy of bifendate in treatment of chronic hepatitis B, a primary study].
Cui S; Wang M; Fan G
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):538-40. PubMed ID: 12133500
[TBL] [Abstract][Full Text] [Related]
37. Impact of interferon-alpha therapy on the serum level of alpha-fetoprotein in patients with chronic viral hepatitis.
Kasztelan-Szczerbińska B; Słomka M; Celiński K; Szczerbiński M
Rocz Akad Med Bialymst; 2003; 48():74-7. PubMed ID: 14737946
[TBL] [Abstract][Full Text] [Related]
38. [Therapeutic effects of Lamivudine in combination with Thymopentin on chronic hepatitis B].
Tang S; Shi W; Zhang W
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):385-7. PubMed ID: 12665914
[TBL] [Abstract][Full Text] [Related]
39. Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis.
Chen C; Li L; Wu Z; Chen H; Fu S
J Infect; 2007 Jan; 54(1):98-102. PubMed ID: 17049992
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and laboratory criteria for assessing the efficacy of Essliver Forte for patients with combined liver and gall bladder pathologies].
Kozlova IV; Antonian AA; Volkov SV
Eksp Klin Gastroenterol; 2006; (4):31-6, 115-6. PubMed ID: 17269421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
